
Aflac Incorporated

AFL (Aflac Incorporated) trades at 3.4x EV/Revenue — attractively valued for a financials company with solid margins (39%) and mature growth profile (-4% YoY). The business is highly profitable at 32% EBIT margins. Forward PE of 14x.
If you invested $1,000 in Amazon at IPO in 1997, it would be worth over $2.1M today. But you would have endured a 95% drawdown in 2001.
Aflac (AFL) is a leading supplemental insurance provider that pays cash benefits directly to policyholders when they face unexpected health events like cancer, accidents, or hospital stays. The company primarily serves individuals and employers in the U.S. and Japan, generating revenue through insurance premiums and investment income on its substantial asset portfolio.
Aflac is focused on expanding its U.S. market presence while maintaining its dominant position in Japan's supplemental insurance market. The company is leveraging digital transformation and partnerships with employers to drive policy sales growth in the mid-single digits annually, with Japan's aging demographics providing a natural tailwind for cancer and medical insurance demand.
The company maintains stable profit margins around 15-17% with strong free cash flow generation exceeding $4 billion annually. Investment yields on Aflac's $140+ billion portfolio remain pressured by low interest rates, but the company has been actively repositioning toward higher-yielding assets while maintaining conservative credit quality.
Aflac holds a unique market position as the largest supplemental insurer globally, with particularly strong brand recognition in Japan where it pioneered the cancer insurance market. Key competitors include MetLife and Prudential, but Aflac's specialized focus and distribution relationships with employers provide competitive advantages that are difficult to replicate.
Limited recent financial data is available, but the company has been executing on strategic initiatives including digital platform investments and expansion of its U.S. group benefits business. The market has generally responded positively to management's capital allocation strategy and consistent dividend growth track record.
Analysts generally view Aflac as a defensive, dividend-focused play within the insurance sector. The primary debate centers on whether the company can accelerate U.S. growth while managing currency headwinds from Japan operations, with most maintaining neutral to positive ratings based on the stable cash flow profile.
Aflac is a steady, dividend-aristocrat insurance company that offers investors predictable cash flows and capital returns, making it attractive for income-focused portfolios despite currency and interest rate headwinds.
Gold Eagle provides data and AI-generated analysis for informational purposes only. Not investment advice. All data from public sources.
Pre-generated investor questions answered by Claude Opus. Available in the Atlas AI tab.








| '25E | '26E | '27E | '28E | |
|---|---|---|---|---|
| Revenue | $17.7B | $17.0B | $17.3B | $17.4B |
| Growth | — | (4%) | +2% | +1% |
| EBITDA | — | $7.1B | $7.2B | $7.3B |
| Growth | — | +2% | +1% | |
| FCF | $2.6B | — | — | — |
| Margin | 14% | — |
Aflac celebrates 20 years as a World's Most Ethical Company
This Stock Pays A ‘Secret' 8%+ Dividend (And Cashes In On AI)
Dividend Income: Lanny's December 2025 Summary
Aflac Incorporated (AFL) Presents at UBS Financial Services Conference 2026 Transcript
| — |
| — |
| EPS (PF) | $7.62 | $7.35 | $7.77 | $8.16 |
| Growth | — | (4%) | +6% | +5% |